Circio Holding ASA

Circio holding asa email format

Verified email-pattern data for Circio Holding Asa is currently limited. You can still use the company insights and contact sections below.
Circio Holding ASA is a clinical stage company developing immune activators to target difficult-to-treat diseases. The company’s mission is to deploy vector-based technology to create a novel class of targeted, multi-functional circRNA medicines. It has established a cutting-edge circular RNA (circRNA) program and is collaborating with Prof Michael Uhlin and a team at the Karolinska Institutet in Stockholm with the intent to develop next generation RNA therapeutics for various applications. The company also has a mutant RAS cancer vaccine program, with two collaborative clinical trials underway in the USA and Norway. It is currently looking at options for the financing of a phase 2 study for ONCOS-102, a genetically modified oncolytic adenovirus.

Company Details

Employees
19
Founded
-
Address
Lilleakerveien 2 C, Oslo,0283,norway
Industry
Biotechnology Research
HQ
Oslo
Looking for a particular Circio Holding ASA employee's phone or email?

Circio Holding Asa Questions

Top Circio Holding ASA Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant